ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma

Affiliations

• ¹ Department of Esophageal Surgery, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ² Department of Esophageal Surgery, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. masayuki.watanabe@jfcr.or.jp.
• ³ Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan.
• ⁴ Department of Surgery, School of Medicine, Keio University, Tokyo, Japan.
• ⁵ Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
• ⁶ Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
• ⁷ Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
• ⁸ Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Hyogo, Japan.
• ⁹ Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.